NO175963C - Fremgangsmåte for fremstilling av et vannopplöselig antibiotisk preparat - Google Patents

Fremgangsmåte for fremstilling av et vannopplöselig antibiotisk preparat

Info

Publication number
NO175963C
NO175963C NO883530A NO883530A NO175963C NO 175963 C NO175963 C NO 175963C NO 883530 A NO883530 A NO 883530A NO 883530 A NO883530 A NO 883530A NO 175963 C NO175963 C NO 175963C
Authority
NO
Norway
Prior art keywords
preparation
water
soluble antibiotic
soluble
antibiotic preparation
Prior art date
Application number
NO883530A
Other languages
English (en)
Norwegian (no)
Other versions
NO175963B (no
NO883530D0 (no
NO883530L (no
Inventor
Kazuo Sakane
Nobuyoshi Yasuda
Shintaro Nishimura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718905A external-priority patent/GB8718905D0/en
Priority claimed from GB878721567A external-priority patent/GB8721567D0/en
Priority claimed from GB878725051A external-priority patent/GB8725051D0/en
Priority claimed from GB878729574A external-priority patent/GB8729574D0/en
Priority claimed from GB888801423A external-priority patent/GB8801423D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO883530D0 publication Critical patent/NO883530D0/no
Publication of NO883530L publication Critical patent/NO883530L/no
Publication of NO175963B publication Critical patent/NO175963B/no
Publication of NO175963C publication Critical patent/NO175963C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO883530A 1987-08-10 1988-08-09 Fremgangsmåte for fremstilling av et vannopplöselig antibiotisk preparat NO175963C (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB878718905A GB8718905D0 (en) 1987-08-10 1987-08-10 Salts of new cephem compounds
GB878721567A GB8721567D0 (en) 1987-09-14 1987-09-14 Salts of cephem compounds
GB878725051A GB8725051D0 (en) 1987-10-26 1987-10-26 Salts of cephem compounds
GB878729574A GB8729574D0 (en) 1987-12-18 1987-12-18 Water-soluble antibiotic composition
GB888801423A GB8801423D0 (en) 1988-01-22 1988-01-22 Water-soluble antibiotic composition

Publications (4)

Publication Number Publication Date
NO883530D0 NO883530D0 (no) 1988-08-09
NO883530L NO883530L (no) 1989-02-13
NO175963B NO175963B (no) 1994-10-03
NO175963C true NO175963C (no) 1995-01-11

Family

ID=27516755

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883530A NO175963C (no) 1987-08-10 1988-08-09 Fremgangsmåte for fremstilling av et vannopplöselig antibiotisk preparat

Country Status (16)

Country Link
US (1) US5104866A (ja)
EP (1) EP0303223B1 (ja)
JP (1) JP2625937B2 (ja)
KR (1) KR970008127B1 (ja)
AR (1) AR243380A1 (ja)
AU (1) AU616677B2 (ja)
CA (1) CA1338780C (ja)
DE (1) DE3885031T2 (ja)
DK (1) DK445188A (ja)
ES (1) ES2059454T3 (ja)
FI (1) FI89927C (ja)
HU (2) HU210848B (ja)
IE (1) IE61679B1 (ja)
IL (1) IL87364A0 (ja)
NO (1) NO175963C (ja)
PT (1) PT88217B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100572323B1 (ko) 2003-12-11 2006-04-19 삼성전자주식회사 멀티레벨 고전압 발생장치
AU2009310959B2 (en) * 2008-10-31 2015-05-07 Shionogi & Co., Ltd. Cephalosporin having catechol group
MX2012011521A (es) 2010-04-05 2013-03-08 Shionogi & Co Compuestos cefem que tienen un grupo catecol.
US8883773B2 (en) * 2010-04-05 2014-11-11 Shionogi & Co., Ltd. Cephem compound having pseudo-catechol group
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AR243380A1 (es) 1993-08-31
DK445188A (da) 1989-02-11
HU210848B (en) 1995-08-28
NO175963B (no) 1994-10-03
NO883530D0 (no) 1988-08-09
AU616677B2 (en) 1991-11-07
IE61679B1 (en) 1994-11-16
IE882365L (en) 1989-02-10
JP2625937B2 (ja) 1997-07-02
EP0303223A2 (en) 1989-02-15
FI89927B (fi) 1993-08-31
PT88217B (pt) 1995-03-01
FI89927C (fi) 1993-12-10
AU2059888A (en) 1989-02-16
DE3885031D1 (de) 1993-11-25
HU211940A9 (en) 1996-01-29
KR970008127B1 (ko) 1997-05-21
IL87364A0 (en) 1989-01-31
ES2059454T3 (es) 1994-11-16
FI883696A (fi) 1989-02-11
HUT47943A (en) 1989-04-28
EP0303223B1 (en) 1993-10-20
FI883696A0 (fi) 1988-08-09
EP0303223A3 (en) 1990-11-28
KR890003782A (ko) 1989-04-18
US5104866A (en) 1992-04-14
JPH01110690A (ja) 1989-04-27
CA1338780C (en) 1996-12-10
DE3885031T2 (de) 1994-02-17
DK445188D0 (da) 1988-08-09
PT88217A (pt) 1989-06-30
NO883530L (no) 1989-02-13

Similar Documents

Publication Publication Date Title
NO177525C (no) FremgangsmÕte for fremstilling av et kombinert anti- inflammatorisk preparat
NO173312C (no) Fremgangsm}te for fremstilling av n{ringsmidler
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO176695C (no) Fremgangsmåte for fremstilling av et smaksmaskert preparat av cefuroksim aksetil
NO179357C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat med forlenget frigivelse
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
PT86875A (pt) Process for the preparation of phenylcarbamate
PT87508A (pt) A process for the preparation of highly soluble clear polyimides
NO885606L (no) Fremgangsmaate for fremstilling av mellomdestillatprodukter
TR23932A (tr) Kaplanmis malzemelerin ueretilmesi icin islem
PT88481A (pt) Process for the preparation of a new cephem compound
PT86800A (pt) Process for the preparation of erythromycin derivatives
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
NO173590C (no) Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
NO174424C (no) Fremgangsmåte for fremstilling av dinatrium-cefodizim
NO175963C (no) Fremgangsmåte for fremstilling av et vannopplöselig antibiotisk preparat
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI873350A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
NO963217L (no) Fremgangsmåte for fremstilling av et salt av clavulansyre
FI893003A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI92064C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
NO176915C (no) Fremgangsmåte for fremstilling av et hirudin-derivat

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002